Orbimed supports the RS - its a no brainer. Why would anyone go against Orbimed. We have common interests. #JT
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint
Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive